UPMC Cancer Centers works in tandem with the University of Pittsburgh Cancer Institute (UPCI), which comprises the academic and research activities for cancer at the University of Pittsburgh and UPMC, to offer patients the latest advances in cancer prevention, detection, diagnosis and treatment.
The Prostate and Urologic Cancer Program's particular areas of research focus on the development of an improved understanding of the biology of prostate and other genitourinary (GU) cancers; new diagnostic and therapeutic approaches to these tumors; and new concepts applicable to the prevention of prostate or other GU cancers.
Patients seen at the Prostate and Urologic Cancer Program have access to many innovative clinical trials, including National Cancer Institute cooperative group studies, industry-sponsored trials and unique, early phase protocols based on research conducted at UPCI.
For more detailed information on the Program's research activities, including current research, accomplishments and future directions, visit the Prostate and Urologic Cancers Program at the University of Pittsburgh Cancer Institute.